Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „Participants“
Suchtreffer
Begriffe & Kennungen
Comirnaty · 4.8 · Immunocompromised participants (adults and children) In study C4591024 (Study 10), a total of 124 immunocompro
Eintrag öffnenComirnaty · 4.8 · Immunocompromised participants (adults and children) In study C4591024 (Study 10), a total of 124 immunocompro
Eintrag öffnenComirnaty · 4.8 · Immunocompromised participants (adults and children) In study C4591024 (Study 10), a total of 124 immunocompro
Eintrag öffnenComirnaty · 4.8 · In Study 4, a placebo-controlled booster study, participants 16 years of age and older recruited from Study 2
Eintrag öffnenComirnaty · 4.8 · In Study 4, a placebo-controlled booster study, participants 16 years of age and older recruited from Study 2
Eintrag öffnenComirnaty · 4.8 · In Study 4, a placebo-controlled booster study, participants 16 years of age and older recruited from Study 2
Eintrag öffnenComirnaty · 4.8 · In Study 4, a placebo-controlled booster study, participants 16 years of age and older recruited from Study 2
Eintrag öffnenComirnaty · 4.8 · In Study 4, a placebo-controlled booster study, participants 16 years of age and older recruited from Study 2
Eintrag öffnenComirnaty · 4.8 · Infants born to pregnant participants – after 2 doses of Comirnaty Study C4591015 (Study 9), a Phase 2/3, plac
Eintrag öffnenComirnaty · 4.8 · Infants born to pregnant participants – after 2 doses of Comirnaty Study C4591015 (Study 9), a Phase 2/3, plac
Eintrag öffnenComirnaty · 4.8 · Infants born to pregnant participants – after 2 doses of Comirnaty Study C4591015 (Study 9), a Phase 2/3, plac
Eintrag öffnenComirnaty · 4.8 · Infants born to pregnant participants – after 2 doses of Comirnaty Study C4591015 (Study 9), a Phase 2/3, plac
Eintrag öffnenComirnaty · 4.8 · Infants born to pregnant participants – after 2 doses of Comirnaty Study C4591015 (Study 9), a Phase 2/3, plac
Eintrag öffnenComirnaty · 4.8 · Participants 12 years of age and older – after a booster dose of Comirnaty Omicron XBB.1.5 (fourth dose or mor
Eintrag öffnenComirnaty · 4.8 · Participants 12 years of age and older – after a booster dose of Comirnaty Omicron XBB.1.5 (fourth dose or mor
Eintrag öffnenComirnaty · 4.8 · Participants 12 years of age and older – after a booster dose of Comirnaty Omicron XBB.1.5 (fourth dose or mor
Eintrag öffnenComirnaty · 4.8 · Participants 12 years of age and older – after a booster dose of Comirnaty Omicron XBB.1.5 (fourth dose or mor
Eintrag öffnenComirnaty · 4.8 · Participants 12 years of age and older – after a booster dose of Comirnaty Omicron XBB.1.5 (fourth dose or mor
Eintrag öffnenComirnaty · 4.8 · Participants 12 years of age and older – after a booster dose of Comirnaty Original/Omicron BA.4-5 (fourth dos
Eintrag öffnenComirnaty · 4.8 · Participants 12 years of age and older – after a booster dose of Comirnaty Original/Omicron BA.4-5 (fourth dos
Eintrag öffnen